500+ HOSPITALS and 85,000+ SCANS/YEAR
RAPID Worldwide Imaging Platform
Automated and Validated ASPECTS
Learn more >
Occlusions revealed within minutes
Learn more >
The most advanced imaging technology at your fingertips
CT and MR compatible
FDA-cleared
CE mark
RAPID predicts cerebrovascular events in patients with stroke
International Journal of Stroke, 2018
Learn more >
Fully automated with unparalleled speed and accessibility
RAPID was superior
Independent clinical study
Stroke, 2016

August 16, 2018

Press Release

iSchemaView's RAPIDTM Approved for Use in Canada
Patients Suffering Ischemic Stroke in Canada Now Have Access to the Only Clinically Validated, Next-Generation Imaging Platform for Assessing Treatment

iSchemaView, the leader in cerebrovascular imaging analysis, today announced it has received final approval for the use of the RAPID platform in Canada.

Read more

August 14, 2018

Press Release

iSchemaView RAPIDTM Technology Now Installed in More Than 500 Stroke Centers - up 48 Percent Since April
Explosive Growth of the De Facto Standard for Advanced Cerebrovascular Imaging

iSchemaView, the leader in cerebrovascular imaging analysis, today announced accelerated adoption of the RAPID advanced imaging platform.

Read more

July 11, 2018

Press Release

iSchemaView Brings RAPIDTM Imaging Platform to Australia and New Zealand Through Exclusive Distributor, Diagnostic Imaging Australia
State-of-the-Art Imaging Solution Provides Automated Scoring and Assessment of Brain Ischemia — Expanding the Treatment Window for Certain Acute Ischemic Strokes to Twenty-Four Hours After Onset

iSchemaView, the leader in cerebrovascular imaging analysis, today announced that the company has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID imaging platform in Australia and New Zealand...

Read more

June 5, 2018

Press Release

iSchemaView Completes MDSAP Audit, Moves to Expand Worldwide Adoption of RAPIDTM Imaging Platform
Critical International Audit Paves Way for Regulatory Application and Approvals Around the World. Canadian Representative Launched.

With MDSAP complete, iSchemaview will be pursuing approval for RAPID in all participating countries, with estimated clearance in Canada expected this summer...

Read more

May 14, 2018

ASSOCIATION OF AMERICAN MEDICAL COLLEGES

Rethinking the Six-Hour Rule for Stroke Victims

Hospitals reexamine treatment protocols after studies show patients can benefit up to 24 hours after stroke symptoms begin...

Read more

May 15, 2018

Press Release

iSchemaView Introduces RAPIDTM ASPECTS
State-of-the-Art Imaging Solution Provides Automated Scoring to Assess Early Signs of Brain Ischemia

Today at the European Stroke Organization Conference, iSchemaView, the leader in automated cerebrovascular imaging analysis, publicly launched RAPID ASPECTS...

Read more


April 24, 2018

Press Release

iSchemaView Technology RAPIDly Adopted by Over 350 Stroke Centers RAPID Becoming a New Standard in Advanced Cerebrovascular Imaging

iSchemaView, the leader in cerebrovascular imaging analysis, today announced accelerating adoption of its platform.

Read more

March 5, 2018

International Journal of Stroke

Perfusion imaging and recurrent cerebrovascular events in intracranial atherosclerotic disease or carotid occlusion.

Large vessel disease stroke subtype carries the highest risk of early recurrent stroke. In this study we aim to look at the association between impaired perfusion and early stroke recurrence in patients with intracranial athero-sclerotic disease or total cervical carotid occlusion.

Read more

January 24, 2018

NBC News

New stroke guidelines extend time frame for life-saving treatment

New guidelines on treating stroke suggest that more people could be eligible for life-saving clot removal and treatments, expanding the "golden window" when doctors can minimize or prevent permanent damage from six to 24 hours.

Read More

January 24, 2018

AHA Stroke Journal

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

These guidelines detail prehospital care, urgent and emergency evaluation and treatment with intravenous and intra-arterial therapies, and in-hospital management, including secondary prevention measures that are appropriately instituted within the first 2 weeks.

Read More

January 24, 2018

ISC conference presentation

DEFUSE 3 Presentation at the Jan. 24 2018 International Stroke Conference in Los Angeles

DEFUSE 3, a 38-center clinical trial sponsored by the National Institutes of Health and led by Stanford researchers, has shown that far more people than previously thought can benefit from existing emergency treatments for acute ischemic stroke.

View Presentation

January 24, 2018

The Washington Post

New research will radically change response to strokes

Advanced brain imaging technology may give doctors an additional 10 hours or more to respond to some strokes, researchers said Wednesday, a development that may soon bring major changes to the way hospitals treat one of the leading causes of disability and death.

Read More